Jpmorgan Chase & Co - Apr 30, 2025 SCHEDULE 13G/A Report for ALTERITY THERAPEUTICS LIMITED American Depositary Shares, each representing 600 Ordinary Shares

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: ALTERITY THERAPEUTICS LIMITED American Depositary Shares, each representing 600 Ordinary Shares
Shares outstanding: 9.15B shares
Disclosed Ownership: 366M shares
Ownership: 4%
Form type: SCHEDULE 13G/A
Date filed: 5/5/2025, 02:03 PM
Date of event: Apr 30, 2025
Previous filing: May 2, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	4%	366M	366M	0	Rachel Tsvaygoft	Vice President